scispace - formally typeset
S

Samuel I. Stupp

Researcher at Northwestern University

Publications -  587
Citations -  54611

Samuel I. Stupp is an academic researcher from Northwestern University. The author has contributed to research in topics: Peptide amphiphile & Supramolecular chemistry. The author has an hindex of 109, co-authored 560 publications receiving 49166 citations. Previous affiliations of Samuel I. Stupp include Urbana University & Max Planck Society.

Papers
More filters
Journal ArticleDOI

Self-assembling Nanostructures to Deliver Angiogenic Factors to Pancreatic Islets

TL;DR: The infiltration of bioactive nanofibers in the interior of islets as an artificial ECM can improve cell viability and function in vitro and enhance their vascularization in the presence of growth factors such as FGF2 and VEGF.
Journal ArticleDOI

Self-assembling quinquethiophene–oligopeptide hydrogelators

TL;DR: Peptidic oligothiophene derivatives self-assemble into 1D nanostructures in aqueous solution as mentioned in this paper, which is the first step towards self-assembly.
Journal ArticleDOI

Nanoapatite and organoapatite implants in bone: Histology and ultrastructure of the interface

TL;DR: Given the biologic reaction observed, these implant materials should be suitable for bone replacement and the organoapatite form could be useful for additional functions such as the release of drugs and optimized release of antibiotics, growth factors, or other substances.
Journal ArticleDOI

Biomimetic Systems for Hydroxyapatite Mineralization Inspired by Bone and Enamel

TL;DR: In this article, a review focused on the formation of hydroxyapatite (HA) in synthetic systems designed primarily in the biomimetic context of bone or enamel mineralization for therapeutic approaches in repair of human tissues.
Journal ArticleDOI

Cholesteryl-(L-lactic acid)n building blocks for self-assembling biomaterials

TL;DR: The synthesis and properties of a novel set of building blocks for the preparation of self-assembling biomaterials are described and the opportunity to introduce additional bioactive substituents such as cholesterol, indomethacin (an antiinflammatory drug), and pyrene and rhodamine B and various α-amino acids is introduced.